Cargando…
No association between the PREP gene and lithium responsive bipolar disorder
BACKGROUND: Bipolar disorder (BD) is a major psychiatric condition that commonly requires prophylactic and episodic treatment. Lithium (Li) has been used for over 40 years now as an effective prophylactic agent. Response to Li treatment seems to be, at least in part, genetically determined. Although...
Autores principales: | Mamdani, Firoza, Sequeira, Adolfo, Alda, Martin, Grof, Paul, Rouleau, Guy, Turecki, Gustavo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1810534/ https://www.ncbi.nlm.nih.gov/pubmed/17324276 http://dx.doi.org/10.1186/1471-244X-7-9 |
Ejemplares similares
-
Synapsin II Is Involved in the Molecular Pathway of Lithium Treatment in Bipolar Disorder
por: Cruceanu, Cristiana, et al.
Publicado: (2012) -
Lithium: a key to the genetics of bipolar disorder
por: Cruceanu, Cristiana, et al.
Publicado: (2009) -
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder
por: Nunes, Abraham, et al.
Publicado: (2021) -
Novel integrative genomic tool for interrogating lithium response in bipolar disorder
por: Hunsberger, J G, et al.
Publicado: (2015) -
Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression
por: Sequeira, Adolfo, et al.
Publicado: (2009)